Comparison

Multiplex Assay Kit for Lactate Dehydrogenase B (LDHB) ,etc. by FLIA (Flow Luminescence Immunoassay)

Item no. LMB698Hu-96T
Manufacturer Cloud-Clone
Amount 96 T
Category
Type Immunofluorescence Assays
Specific against Human (Homo sapiens)
Sensitivity The minimum detectable dose of this kit is typically less than 0.007 ng/mL
ECLASS 10.1 32160701
ECLASS 11.0 32160701
UNSPSC 41116126
Alias LDH-B,LDH-H,Renal carcinoma antigen NY-REN-46
Available
Manufacturer - Applications
FLIA Kit for Antigen Detection.
Manufacturer - Category
FLIA Kit
Sample type
Serum, plasma, tissue homogenates and other biological fluids
Assay length
3h
Method
Double-antibody Sandwich
Specificity

This assay has high sensitivity and excellent specificity for detection of Lactate Dehydrogenase B (LDHB) , etc. by FLIA (Flow Luminescence Immunoassay).

No significant cross-reactivity or interference between Lactate Dehydrogenase B (LDHB) , etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Lactate Dehydrogenase B (LDHB) , etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.

Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Lactate Dehydrogenase B (LDHB) , etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.

CV(%) = SD/meanX100

Intra-Assay: CV<10%

Inter-Assay: CV<12%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.

To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;

2. Add 100μL standard or sample to each well,

        add 10μL magnetic beads, and incubate 90min at 37° C on shaker;

3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37° C on shaker;

4. Wash plate on magnetic frame for three times;

5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37° C on shaker;

6. Wash plate on magnetic frame for three times;

7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
Test principle
Analyte-specific antibodies are pre-coated onto color-coded microparticles. Microparticles, standards, and samples are pipetted into wells and the immobilized antibodies bind the analytes of interest. After washing away any unbound substances, a biotinylated antibody cocktail specific to the analytes of interest is added to each well. Following a wash to remove any unbound biotinylated antibody, Streptavidin-Phycoerythrin conjugate (Streptavidin-PE), which binds to the biotinylated detection antibodies, is added to each well. A final wash removes unbound Streptavidin-PE and the microparticles are resuspended in buffer and read using the Luminex or Bio-Plex analyzer.The MFI developed is
proportional to the concentration of analytes of interest in the sample.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 96 T
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close